BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4438349)

  • 1. Plasma glucose, insulin, pancreatic, and enteroglucagon levels in normal and depancreatized dogs.
    Matsuyama T; Foà PP
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):97-102. PubMed ID: 4438349
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs.
    Vranic M; Pek S; Kawamori R
    Diabetes; 1974 Nov; 23(11):905-12. PubMed ID: 4430418
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs.
    Valverde I; Dobbs R; Unger RH
    Metabolism; 1975 Sep; 24(9):1021-8. PubMed ID: 1152674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine infusion in dogs. Model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels.
    Cherrington AD; Kawamori R; Pek S; Vranic M
    Diabetes; 1974 Oct; 23(10):805-15. PubMed ID: 4422477
    [No Abstract]   [Full Text] [Related]  

  • 7. Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.
    Matsuyama T; Namba M; Nonaka K; Tarui S; Tanaka R; Shima K
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():115-9. PubMed ID: 7014201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of galanin on plasma glucose, insulin and pancreatic glucagon in dogs.
    Manabe T; Okada Y; Sawai H; Funahashi H; Yamamoto M; Hayakawa T; Yoshimura T
    J Int Med Res; 2003; 31(2):126-32. PubMed ID: 12760316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of immunoreactive insulin, glucagon and pancreatic polypeptide in the plasma of depancreatized chickens.
    Colca JR; Hazelwood RL
    J Endocrinol; 1982 Mar; 92(3):317-26. PubMed ID: 7040582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of truncal and selective vagotomy on the release of pancreatic glucagon, insulin and enteroglucagon.
    Russell RC; Thomson JP; Bloom SR
    Br J Surg; 1974 Oct; 61(10):821-4. PubMed ID: 4416224
    [No Abstract]   [Full Text] [Related]  

  • 11. Change of glucagon reacting to 30 K antibody in totally depancreatized dogs.
    Sudo T; Konishi K; Nakase A; Suzuki T; Nishimura I; Tobe T
    Gastroenterol Jpn; 1978; 13(2):119-26. PubMed ID: 669196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
    Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glucagon-like immunoreactivity (GLI) in dogs.
    Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
    Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic and intestinal glucagon in the duck.
    Krug E; Mialhe P
    Horm Metab Res; 1971 Jan; 3(1):24-7. PubMed ID: 5128325
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of extrapancreatic glucagon to glycemic changes under chronic insulin deficiency in dogs.
    Kobayashi T; Nihei J; Ohneda A
    Tohoku J Exp Med; 1983 Dec; 141(4):481-8. PubMed ID: 6367144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capacity to secrete islet hormones after subtotal pancreatectomy for pancreatic cancer.
    Ahrén B; Andrén-Sandberg A
    Eur J Surg; 1993 Apr; 159(4):223-7. PubMed ID: 8102543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glucagon and of insulin on serum free fatty acids in normal and depancreatized dogs.
    Whitty AJ; Shima K; Trubow M; Foà PP
    Proc Soc Exp Biol Med; 1969 Jan; 130(1):55-61. PubMed ID: 5762527
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucagon interaction in the pancreatic duodenal axis.
    Nutr Rev; 1969 Mar; 27(3):90-2. PubMed ID: 5783690
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.